cell therapy
| 8 min read
Doctors are recording a wave of wins using cord blood to heal sick children. The clinical evidence suggests that more wins may come.
| 3 min read
Allogeneic T cells may serve as universal, ready-to-use therapeutic agents for large scale clinical applications.
| 8 min read
By activating CAR T cells only in the presence of an antibody switch, Travis Young and his team hope to make this cancer treatment safer and more effective.
The early steps of viral vector production influence cell and gene therapy success.
The immune system comprises a treasure trove of cell types with the potential to destroy cancer cells.
Available on Demand
Learn how scientists leverage the power of natural killer cells to fight cancer.
Available on Demand
LIVE JUNE 23rd, 2022 at 2:30 PM
Uncover genomic and epigenomic variations within a group of cells using single cell sequencing.
Uncover genomic and epigenomic variations within a group of cells using single cell sequencing.
Available on Demand
LIVE October 13th, 2021 at 10:30 AM ET
Experts will discuss advances that bring CAR therapy for solid tumors one step closer to reality.
Experts will discuss advances that bring CAR therapy for solid tumors one step closer to reality.
Available on Demand
LIVE September 22nd, 2021 at 2:30 PM ET
Scientists will discuss how they identify and design new cell-based anticancer treatments and how they balance the need for potency with the specter of side effects.
Scientists will discuss how they identify and design new cell-based anticancer treatments and how they balance the need for potency with the specter of side effects.
| 3 min read
Cell-based therapies could provide an advantageous alternative, but the development of these new therapies is often impaired and delayed by the lack of an appropriate model to test their safety and efficacy in humans before embarking in clinical trials.
